Advanced Search

Technical Analysis for CUE - Cue Biopharma, Inc.

Grade Last Price % Change Price Change
F 13.0 -2.62% -0.35
CUE closed down 2.62 percent on Tuesday, March 2, 2021, on 48 percent of normal volume. It ran into resistance at its 50 day moving average.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical CUE trend table...
Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
50 DMA Resistance Bearish -2.62%
Spinning Top Other -2.62%
Pocket Pivot Bullish Swing Setup -4.48%
Lower Bollinger Band Touch Weakness -4.48%
50 DMA Resistance Bearish -1.74%
Oversold Stochastic Weakness -1.74%
50 DMA Resistance Bearish -2.77%
MACD Bearish Centerline Cross Bearish -2.77%
Stochastic Buy Signal Bullish -2.77%
Older End-of-Day Signals for CUE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Fell Below Previous Day's Low about 20 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
Down 2 % about 21 hours ago
Down 1% about 23 hours ago
50 DMA Resistance about 23 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators Basic chart:

Profile

Cue Biopharma Inc is a biopharmaceutical company developing a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Cancer Life Sciences Pharmaceutical Industry Immune System Pharmacy Cancers Medication Specialty Drugs Autoimmunity Immune Disorders Autoimmune Disorders

Is CUE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Mar 1 Cue Biopharma to Present at the Cowen 41st Annual Health Care Conference
Feb 25 Cue Biopharma Enhances Scientific Advisory Board with Appointments of Immunology and Immunotherapy Experts Dr. Abul K. Abbas and Dr. Michael Kalos
Feb 23 What Is The Ownership Structure Like For Cue Biopharma, Inc. (NASDAQ:CUE)?
Feb 22 Cue Biopharma to Present at the 7th Annual Immuno-Oncology 360° Conference
Feb 17 Cue Biopharma Announces Appointment of Matteo Levisetti, M.D. as Senior Vice President of Clinical Development
Feb 8 Cue Biopharma Initiates Patient Dosing in Phase 1 Study of CUE-101 in Combination with KEYTRUDA® (pembrolizumab) as First-line Treatment for HPV+ Recurrent/Metastatic Head and Neck Cancer
Jan 29 7 Stocks With Insider Buying This Week Worth A Look
Jan 9 How Much Are Cue Biopharma, Inc. (NASDAQ:CUE) Insiders Spending On Buying Shares?
Jan 7 Cue Biopharma: CUE-101's Phase 1 Promising Progress, 1 New IND Expected, Funding Until Q2 2022
Dec 16 Is CUE A Good Stock To Buy Now?
See more CUE news...

Indicators

Indicator Value
52 Week High 31.69
52 Week Low 9.3
Average Volume 302,668
200-Day Moving Average 17.43
50-Day Moving Average 13.70
20-Day Moving Average 14.45
10-Day Moving Average 13.58
Average True Range 0.94
ADX 24.43
+DI 12.75
-DI 26.16
Chandelier Exit (Long, 3 ATRs ) 13.92
Chandelier Exit (Short, 3 ATRs ) 15.07
Upper Bollinger Band 16.47
Lower Bollinger Band 12.43
Percent B (%b) 0.14
BandWidth 27.93
MACD Line -0.22
MACD Signal Line 0.02
MACD Histogram -0.2349
Fundamentals Value
Market Cap 393.62 Million
Num Shares 30.3 Million
EPS -2.20
Price-to-Earnings (P/E) Ratio -5.92
Price-to-Sales 98.18
Price-to-Book 4.66
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 14.37
Resistance 3 (R3) 14.50 14.18 14.14
Resistance 2 (R2) 14.18 13.83 14.11 14.06
Resistance 1 (R1) 13.59 13.62 13.43 13.46 13.99
Pivot Point 13.27 13.27 13.19 13.20 13.27
Support 1 (S1) 12.68 12.92 12.52 12.55 12.01
Support 2 (S2) 12.36 12.71 12.29 11.94
Support 3 (S3) 11.77 12.36 11.86
Support 4 (S4) 11.64